Canada · Health Canada Drug Product Database
ENDANGITIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 1442
- DIN
- 00245518
- Form
- Liquid
- Company as listed by source
- DR RECKEWEG AND CO
- Source status
- Cancelled Post Market (1997-10-21)
- Source last updated
- 2025-03-22
Source-listed ingredients
- EPINEPHRINE — 6 X — per 1 X
- AESCULUS HIPPOCASTANUM — 2 X — per 1 X
- CUPRIC ACETATE — 6 X — per 1 X
- POTENTILLA ANSERINA — 2 X — per 1 X
- ERGOT — 4 X — per 1 X
- TOBACCO — 4 X — per 1 X
- WHITE HELLEBORE ROOT — 6 X — per 1 X
These values do not establish equivalence or a dose recommendation.
Packages
- 20cc,22ml,50ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →